IRIS
MORRETTA, ELVA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 203
EU - Europa 147
AS - Asia 134
AF - Africa 12
SA - Sud America 1
Totale 497
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 200
SG - Singapore 113
IT - Italia 111
CI - Costa d'Avorio 12
CN - Cina 12
DE - Germania 9
JP - Giappone 6
NL - Olanda 6
FI - Finlandia 5
FR - Francia 5
GB - Regno Unito 4
AT - Austria 2
CA - Canada 2
LA - Repubblica Popolare Democratica del Laos 2
UA - Ucraina 2
AR - Argentina 1
BE - Belgio 1
IN - India 1
LV - Lettonia 1
MX - Messico 1
RU - Federazione Russa 1
Totale 497
Salva come PNG Salva come JPEG
Città #
Singapore 93
Santa Clara 65
Naples 47
Chandler 13
Ashburn 8
Kronberg 7
Formia 6
Lawrence 6
Lappeenranta 5
Amsterdam 4
Beijing 4
Millbury 4
Ancona 3
Angri 3
Boston 3
Cambridge 3
Des Moines 3
London 3
Milan 3
Okayama 3
Rome 3
Salerno 3
San Gennaro Vesuviano 3
Tokyo 3
Torre Annunziata 3
Turin 3
Acerra 2
Burlington 2
Irpin 2
Orta di Atella 2
Padenghe sul Garda 2
Toronto 2
Trento 2
Uta 2
Vientiane 2
Wilmington 2
Ahome 1
Bacoli 1
Birmingham 1
Boardman 1
Brussels 1
Cardito 1
Corsico 1
Ercolano 1
Fairfield 1
Guangzhou 1
Hangzhou 1
Innsbruck 1
Los Angeles 1
New Delhi 1
Newark 1
Paris 1
Prineville 1
Qingdao 1
Reims 1
Riga 1
Sandston 1
Seattle 1
Temple Hills 1
The Hague 1
Vienna 1
Yantai 1
Totale 350
Salva come PNG Salva come JPEG
Nome #
Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches 36
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 34
Involvement of 3′,5′-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular tone 31
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 26
PROTEOMICS-AIDED INSIGHT TO DISCLOSE NATURAL PRODUCTS CELLULAR TARGETS 24
Drug Repositioning for Fabry Disease: Acetylsalicylic Acid Potentiates the Stabilization of Lysosomal Alpha-Galactosidase by Pharmacological Chaperones 24
Discovering the biological target of 5-epi-sinuleptolide using a combination of proteomic approaches 20
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 19
Opposite effects of the FXR agonist obeticholic acid on Mafg and Nrf2 mediate the development of acute liver injury in rodent models of cholestasis 19
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 18
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling 18
Identifying Natural Products Targetome: the case of Artemetin. 17
Curcumin Has Beneficial Effects on Lysosomal Alpha-Galactosidase: Potential Implications for the Cure of Fabry Disease 16
Atorvastatin protects against liver and vascular damage in a model of diet induced steatohepatitis by resetting FXR and GPBAR1 signaling 14
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH 13
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 13
Transcriptome analysis of dual FXR and GPBAR1 agonism in rodent model of NASH reveals modulation of lipid droplets formation 13
High levels of soluble CD73 unveil resistance to BRAF inhibitors in melanoma cells 13
Interactome analysis of bioactive molecules: optimization of a label-free functional proteomics platform 11
Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2 11
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease 11
Drug affinity-responsive target stability unveils filamins as biological targets for artemetin, an anti-cancer flavonoid 10
Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents 10
Role of Intracellular and Extracellular Annexin A1 in MIA PaCa-2 Spheroids Formation and Drug Sensitivity 10
Identification of Mortalin as the Main Interactor of Mycalin A, a Poly-Brominated C-15 Acetogenin Sponge Metabolite, by MS-Based Proteomics 9
Development of dual GPBAR1 agonist and RORγt inverse agonist for the treatment of inflammatory bowel diseases 9
Carbamoyl-Phosphate Synthase 1 as a Novel Target of Phomoxanthone A, a Bioactive Fungal Metabolite 8
Deconvolution of bioactive molecules: label-free functional proteomics to investigate the cytotoxic compound LAM20 target(s) profile 8
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy 8
H3K56 acetylation affects Candida albicans morphology and secreted soluble factors interacting with the host. 8
A functional proteomics-based platform to disclose small molecules cellular targets 6
A multidisciplinary functional proteomics-aided strategy as a tool for the profiling of a novel cytotoxic thiadiazolopyrimidone 6
Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor 6
Carbamoyl-phosphate synthase 1 as a novel target of phomoxanthone a, a bioactive fungal metabolite 5
Synthesis, functional proteomics and biological evaluation of new 5-pyrazolyl ureas as potential anti-angiogenic compounds 5
Interactome analysis of bioactive molecules: optimization of a label-free functional proteomics platform 5
Triterpenes from Boswellia serrata as a New Chemotype of Leukaemia Inhibitory Factor Receptor Antagonists. 5
Label-free functional proteomics links the anti-angiogenic properties of the pyrazolyl-urea GeGe-3 to Calreticulin binding. 5
Label-Free Quantitative Proteomics to Explore the Action Mechanism of the Pharmaceutical-Grade Triticum vulgare Extract in Speeding up Keratinocyte Healing 5
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G‐Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease 5
Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomics 4
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 4
Targeting USP-7 by a Novel Fluorinated 5-Pyrazolyl-Urea Derivative 4
null 3
Functional Proteomics Ties Calreticulin with the Anti-Angiogenic Properties of the Pyrazolyl-Urea GeGe-3 3
Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities 3
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2 1
Totale 556
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.773
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202 0 0 0 0 0 0 0 0 0 0 2 0
2020/20218 1 0 3 0 0 0 3 1 0 0 0 0
2021/202225 0 0 0 0 0 0 0 3 3 1 8 10
2022/202366 6 3 3 1 9 5 11 5 10 5 7 1
2023/2024169 3 5 13 3 1 6 17 21 10 6 53 31
2024/2025284 58 58 11 37 49 71 0 0 0 0 0 0
Totale 556